Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SOWAHC | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
mRNA | NOTCH1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | HYLS1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
mRNA | ZNF565 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | TYR | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
mRNA | CENPI | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | RRP12 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | PDCL3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
mRNA | FBXO33 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | IGSF8 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |